Genetics of endocrine disease: Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4041-4046

  Stratakis, Constantine A ^a   Kirschner, Lawrence S ^a   Carney, J Aidan ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

AUTOSOMAL DOMINANT DISORDER; CARNEY COMPLEX; CHROMOSOMAL LOCALIZATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; EVALUATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; HETEROZYGOSITY; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SERTOLI CELL TUMOR; SKIN DISEASE; TUMOR SUPPRESSOR GENE; ADRENAL CORTEX TUMOR; GENETICS; SYNDROME;

ADRENAL CORTEX NEOPLASMS; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; SYNDROME;

EID: 0034853288     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.9.4041     Document Type: Review

References (41)

1. Primary pigmented nodular adrenocortical disease and its associated conditions
2. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity
3. The complex of myxomas, spotty pigmentation, and endocrine overactivity
4. A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: The NAME syndrome
5. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: The "LAMB" syndrome
6. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes
7. A concise genetic and clinical guide to multiple endocrine neoplasia and related syndromes
8. Carney complex: Diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas
9. Paradoxical response to dexamethasone assists with the diagnosis of primary pigmented nodular adrenocortical disease (PPNAD)
10. Neurosurgical implications of Carney complex
11. Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex)
12. Pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex): Evidence for progression from somatomammotroph hyperplasia to adenoma
13. Thyroid gland abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity" (Carney complex)
14. Testicular ultrasound in Carney complex
15. Ovarian cysts in patients with Carney complex: Clinical and genetic studies and evidence for predisposition to cancer
16. Epithelioid blue nevus and psammomatous melanotic schwannoma: The unusual pigmented skin tumors of the Carney complex
17. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome
18. Ductal adenoma of the breast with tubular futures. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas
19. Ductal adenoma of the breast
20. Osteochondromyxoma of bone: A congenital tumor associated with lentigines and other unusual disorders
21. Carney Complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2
22. Genetics of Carney complex: Parent of origin effects and putative non-Mendelian features in an autosomal dominant disorder; absence of common defects of the ACTH receptor and RET genes
23. Parent-of-origin effects in multiple endocrine neoplasia type 2B
24. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome
25. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex
26. Gigantism
27. Malignant large-cell calcifying Sertoli cell tumor of the testis
28. Autosomal dominant transmission of the NAME syndrome (nevi, atrial myxoma, mucinosis of the skin and endocrine overactivity)
29. The aromatase excess syndrome is associated with feminization in both sexes and autosomal dominant transmission of aberrant P450arom gene transcription
30. Spectrum of malignancy and premalignancy in Carney syndrome
31. Primare pigmentierte nodulare adrenocortikale dysplasie (PPNAD) im rahmen des carney-komplexes als ursache eines cushing-syndroms
32. Genetic heterogeneity of familial atrial myxoma syndromes (Carney complex)
33. A refined genetic, radiation hybrid, and physical map of the Carney complex (CNC) locus on chromosome 2p16; evidence for genetic heterogeneity in the syndrome
34. Mutations of the PRKAR1A gene in patients with Carney complex
35. Mutations in the protein kinase A Rlα regulatory subunit cause familial cardiac myxomas and Carney complex
36. Coupling gene expression to cAMP signalling: Role of CREB and CREM
37. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with Carney complex
38. Genetic heterogeneity in Carney complex (OMIM 160980): Contributions of loci at chromosomes 2 and 17 in its genetics
39. The familial lentiginosis syndromes are emerging from the obscurity imposed by rarity: New genes and genetic loci for multiple tumors and developmental defects
40. Syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex): Breast imaging findings